Fig.4c indicated that CX3CR1+PBDCs increased the expression of IL-13Ra1 and MHCII following CAS+NP-OVA treatment, which mimics secondary allergen sensitization in human AD patients. The gene discussed is CX3CR1; the disease is Alzheimer disease.